Naoyuki G. Saito, M.D., Ph.D.
2 clinical trials · Sponsor
◉ Watch Naoyuki G. Saito, M.D., Ph.D.
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic Malignancies (NCT05201183) | Naoyuki G. Saito, M.D., Ph.D. | 2023-10-01 |
| IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT (NCT03696537) | Naoyuki G. Saito, M.D., Ph.D. | 2018-08-29 |
Track Naoyuki G. Saito, M.D., Ph.D. automatically
Every clearance here is in the API, with alerts when new ones post.